PubMed Health⌕ Search

Biomedical subjects

Steven Kymes

Publications and source records attributed to Steven Kymes.

5 recordsLinked to original sources
PubMed2006

A transgenic mouse model for human autosomal dominant cataract.

PURPOSE: To characterize lenses from transgenic mice designed to express mutant and wild-type alphaA-crystallin subunits. METHODS: A series of transgenic mouse strains was created to express mutant (R116C) and wild-type human alphaA-crystallin in fiber cells of the lens. Dissected lenses were phenotypically scored for the presence and extent of opacities, fiber cell morphology, and posterior suture morphology. Gene transcripts derived from integrated transgenes were detected by reverse transcriptase-PCR. Distribution of expressed transgenic protein was determined by immunohistochemical staining of lens tissue sections. The abundance of endogenous and transgenic lens proteins was estimated by quantitative Western blot analysis. RESULTS: Expression of R116C mutant alphaA-crystallin subunits resulted in posterior cortical cataracts and abnormalities associated with the posterior suture. The severity of lens abnormalities did not increase between the ages of 9 and 30 weeks. With respect to opacities and morphologic abnormalities, lenses from transgenic mice that express wild-type human alphaA-crystallin subunits were indistinguishable from age-matched nontransgenic control mice. Similar phenotypes were observed in different independent lines of R116C transgenic mice that differed by at least two orders of magnitude in the expression level of the mutant transgenic protein. CONCLUSIONS: The results show that lens opacities and posterior sutural defects occur when mutant R116C alphaA-crystallin subunits are expressed on the background of wild-type endogenous mouse alpha-crystallins. Low levels of R116C alphaA-crystallin subunits are sufficient to induce lens opacities and sutural defects.

Animals↗
PubMedDate not supplied

Incidence of corneal epithelial defects with the standard and zero-compression hansatome microkeratomes.

PURPOSE: To evaluate the incidence of epithelial defects in patients who have had laser in situ keratomileusis (LASIK) surgery with the standard compression Hansatome microkeratome head in comparison to the modified (zero-compression) Hansatome microkeratome head (Bausch & Lomb, Rochester, NY). METHODS: This study was a retrospective review of 404 consecutive patients who had LASIK surgery on both eyes between January 2002 and June 2002. The standard compression microkeratome head was used in 216 (53%) cases and the zero-compression microkeratome head was used in 188 (47%) cases. Epithelial defects were categorized as loose epithelium, or a break in the epithelium, within the area of the flap. An adverse outcome for a patient was defined as having an epithelial defect in at least one eye. Odds ratios were estimated using logistic regression. RESULTS: When the standard compression microkeratome head was used, 19 (8.8%) patients had an epithelial defect in at least 1 eye. When the zero-compression microkeratome head was used, 5 (2.7%) patients had an epithelial defect in at least 1 eye. Logistic regression comparing the risk of epithelial defect in either eye with the standard compression head versus the zero-compression head resulted in an age-adjusted odds ratio of 0.2 (95% confidence interval, 0.07 to 0.58, P < .05). CONCLUSIONS: These findings provide evidence that LASIK surgery with a zero-compression head reduces the risk of epithelial defect compared to the standard compression head of the Hansatome microkeratome.

Adult↗